Go Green This New Year - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Go Green This New Year


Pharmaceutical Technology


Angie Drakulich
As we get ready to head into the new year, chief executive and financial officers may be making their wish lists for 2008. Grow revenue. Increase pipeline. Establish new facility abroad. Acquire small-sized generics company. And so forth. But why not add something "green" to the list?Why not consider ways to help the environment while aiming for success?

Several companies are already on board. Take Cardinal Health, which is expanding its Dublin, Ohio, headquarters to house the company's Healthcare Supply Chain Services sector. The new facility is up for Leadership in Energy and Environmental Design (LEED)certification—and if approved, will be the first in Dublin to receive the honor. A project of the USGreen Building Council, LEED provides nationally accepted benchmarks for high-performance green buildings. More than 1050buildings in the US, and 1120 worldwide, have been LEED certified, meaning they meet certain sustainable development, water savings, energy efficiency, materials selection, and indoor environmental quality standards.

On the processing side, Materia (Pasadena, CA) has licensed its metathesis platform to Merck (Whitehouse Station, NJ), Aileron Therapeutics (Cambridge, MA), and Eisai (Tokyo) during the past year. Materia's catalysts help to synthesize potential new drugs with fewer byproducts and less hazardous waste.

College students are also getting into the green game. With the help of USEnvironmental Protection Agency grants, New Jersey's Rowan University is working with Bristol-Myers Squibb (BMS) (New York) and Novartis (Basel, Switzerland) to develop green engineering designs and practices. The BMS group is specifically looking at a solvent pervaporation project that could reduce carbon dioxide emissions and cut costs.

So here's to becoming a follower and a leader at the same time. Add "go green"to your comany's list of New Year's resolutions.









Angie Drakulich is the managing editor of Pharmaceutical Technology,

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
27%
Breakthrough designations
9%
Protecting the supply chain
41%
Expedited reviews of drug submissions
9%
More stakeholder involvement
14%
View Results
Jim Miller Outsourcing Outlook Jim Miller Health Systems Raise the Bar on Reimbursing New Drugs
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerThe Mainstreaming of Continuous Flow API Synthesis
Jill Wechsler Regulatory Watch Jill Wechsler Industry Seeks Clearer Standards for Track and Trace
Siegfried Schmitt Ask the Expert Siegfried SchmittData Integrity
Sandoz Wins Biosimilar Filing Race
NIH Translational Research Partnership Yields Promising Therapy
Clusters set to benefit from improved funding climate but IP rights are even more critical
Supplier Audit Program Marks Progress
FDA, Drug Companies Struggle with Compassionate Use Requests
Source: Pharmaceutical Technology,
Click here